Involvement of GABAergic pathway in the sedative activity of apigenin, the main flavonoid from Passiflora quadrangularis pericarp  by Gazola, Andressa C. et al.
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In the  current  study  we  showed  that  oral  administration  of  an aqueous  extract  of Passiﬂora  quadrangularis
L.,  Passiﬂoraceae,  pericarp  results  in  a signiﬁcant  prolongation  of  the sleep  duration  in mice  evaluated  in
the  ethyl  ether-induced  hypnosis  test  which  indicates  sedative  effects.  Apigenin,  the  main  ﬂavonoid  of
the  extract,  induced  a similar  sedative  response  when  applied  alone,  at a dose  equivalent  to  that  found
in  the  extract,  suggesting  that  apigenin  is mediating  the sedative  effects  of  P. quadrangularis  extract.  In
addition,  the sedative  effect  of apigenin  was  blocked  by  pretreatment  with  the benzodiazepine  antag-
onist  ﬂumazenil  (1 mg/kg),  suggesting  an  interaction  of apigenin  with  gamma-aminobutyric  acid  typeassiﬂora quadrangularis
assion ﬂower
assion fruit
edative
A (GABAA)  receptors.  However,  apigenin  at concentrations  0.1–50  M failed  to  enhance  GABA-induced
currents  through  GABAA receptors  (122S) expressed  in Xenopus  oocytes.  Nevertheless,  based  on  our
results,  we  suggest  that  the  in  vivo sedative  effect  of  the  P.  quadrangularis  extract  and  its main  ﬂavonoid
apigenin  maybe  be  due  to  an enhancement  of  the GABAergic  system.
© 2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
The genus Passiﬂora has the most economical signiﬁcance
mong all other genera in the family Passiﬂoraceae. Its species are
ainly distributed throughout Latin America. Passiﬂora quadrangu-
aris L. is usually cultivated at altitudes below 2500 m (Killip, 1938).
n Brazil, the occurrence of this species is described in the states of
mazonas and Maranhão (Cervi, 1997) and also in Colombia, in
he regions of Chocó, Meta, Huila and Santander. Popularly known
s “maracujá-ac¸ u” in Brazil (Cervi, 1997) and “badea” in Colombia
Hernández and Bernal, 2000), this species is widely consumed in
olombia as juice. The fruits are much bigger than the other fruits
f Passiﬂora species showing pale yellowish green color when ripe
Vanderplank, 2000).
To date, only few pharmacological and chemical studies with
ericarps of Passiﬂora species is available. In traditional medicine,
reparations using leaves of some species are used as sedatives and
ild tranquilizers (Lewis and Elvin-Lewis, 1977; Schindler, 1884).
n particular, sedative, anxiolytic-like and anticonvulsant effects
∗ Corresponding author.
E-mail: andressa@unibave.net (A.C. Gazola).
http://dx.doi.org/10.1016/j.bjp.2015.03.009
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraof leaves extracts from different species of Passiﬂora have been
reported (for a review, see Dhawan et al., 2004).
Regarding the chemical composition, most of the studies is also
related to leaves extracts and reported the presence of ﬂavonoids
(Petry et al., 1998; Ulubelen et al., 1982; Zucolotto et al., 2012)
and saponins (Orsini et al., 1985; Reginatto et al., 2001). In this
respect, due the lack in the literature about neuropharmacological
and chemical data of pericarp from Passiﬂora species and consid-
ering that the sedative and anxiolytic-like activities of P. edulis var.
ﬂavicarpa pericarp were previously described (Sena et al., 2009),
the aim of the present study was  to evaluate the sedative activity
of P. quadrangularis pericarp aqueous extracts, the correlation of the
sedative activity to its ﬂavonoids constituents besides to study the
involvement of the gamma-aminobutyric acid system in the action
of these compounds.
Materials and methods
Plant material and extractionFruits of Passiﬂora quadrangularis L., Passiﬂoraceae, were
collected in Colombia [Neiva, Huila (2◦59′55′′, −75◦18′16′′)], iden-
tiﬁed by Prof. Luis Carlos Jimenez (Instituto Nacional de Ciencias,
 Ltda. All rights reserved.
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niversidad Nacional de Colombia) and a voucher specimen
as deposited in the Herbarium of the Universidad Nacional de
olombia (COL 572634).
Extract for the ethyl ether-induced hypnosis test as well as the
PLC-DAD analyses was obtained as follows. Fresh pericarp was
irectly extracted by infusion with hot water (90 ◦C; plant:solvent,
:3, w/v) for 10 min. The aqueous extracts were subsequently ﬁl-
ered and freeze-dried.
PLC-DAD analyses
The analyses were performed on a PerkinElmer Series 200 high-
erformance liquid chromatography (HPLC) system equipped with
iode array detection (DAD), quaternary pump, online degasser
nd auto-sampler (injection volume was 20 l). The separation
as performed with a PerkinElmer Brownlee Analytical C18 col-
mn  (250 mm × 4.6 mm i.d.; 5 m).  The ﬂow was  maintained at a
onstant rate of 1.2 ml/min. The mobile phase used consisted of
olvent A (acetonitrile) and solvent B (0.5% formic acid in water)
n a linear gradient elution (0–20 min– 15% – 35% of A; 20–25 min
 isocratic 35% A). The chromatograms were monitored at 340 nm
nd UV spectra were recorded in the 200–400 nm range. The data
ere processed with Chromera software® (Version 3.2.0.4847)
PerkinElmer®, Waltham, MA,  USA).
Qualitative and quantitative analyses were performed with
he extract in a concentration of 5000 g/ml. For qualitative
nalyses the reference standards co-eluted with the extract
ere apigenin (≥95% – Sigma–Aldrich®, USA), isoorientin (≥98%
 Extrasynthèse®, France), vitexin-2′′-O-rhamnoside (≥98% –
igma–Aldrich®, USA), vitexin-2′′-O-xyloside (Costa et al., 2013),
sovitexin (≥98% – Fluka®, USA) and swertisin (Santos et al., 1996).
The quantitative analyses were developed using the external
tandard method, being apigenin used as a reference substance to
reate a calibration curve with six points in a 0.5–40 g/ml con-
entration range. All of the standard solutions were analyzed in
riplicate, and the average peak areas were measured. The vali-
ation of the analytical procedures was performed in accordance
ith ICH guidelines (2005). In particular, the following parame-
ers were evaluated: speciﬁcity, linearity, accuracy, precision (both
epeatability and intermediate precision), the limit of quantiﬁca-
ion (LOQ) and the limit of detection (LOD).
nimals
Male adult Swiss mice (3–4 months) weighing 35–50 g were
sed for behavioral evaluations. Animals were maintained on a
2-h light-dark cycle (lights on at 7 a.m.) at a constant room temper-
ture (23 ± 2 ◦C). Mice were housed in groups of twenty per plastic
age (30 cm × 37 cm × 16 cm)  with food and water provided ad libi-
um except during the experiments. All animals were allowed to
dapt to the laboratory conditions for at least one week prior to
he behavioral assessments of the study. On the day of the exper-
ment, animals were housed in the experimental room for at least
 h prior to the start of the testing procedures. Each animal was
sed only once. Experiments were conducted in accordance with
ational and international standards of animal welfare (Brazilian
aw #11,794, 10/08/2008; NIH publication #85-23, revised in 1996)
nd approved by the local Committee for Animal Care in Research
#23080.044085/2009-37/CEUA/UFSC). All efforts were made to
inimize the number of animals used and their suffering.
rugs and treatmentsMice were orally treated (p.o.) through an intragastric cannula,
n a constant volume of 0.1 ml/10 g of animal weight, with P. quad-
angularis aqueous extract or apigenin, both dissolved in distilledrmacognosia 25 (2015) 158–163 159
water. In the ethyl ether-induced hypnosis test, the extract was
tested at the doses of 100, 300 and 600 mg/kg and apigenin was
tested at the doses of 0.1, 0.3, 0.6 and 1.0 mg/kg. An equal volume
of distilled water (vehicle, p.o.) treated mice of the control groups.
Diazepam (DZP – Hoffman-La Roche®, Switzerland) was used as
positive drug control, dissolved in water with 10% of propylene
glycol, and administered p.o.  at a dose of 1 mg/kg in the sedative
test (Sena et al., 2009). Animals were individually tested 1 h after
their treatments with the extract or apigenin and 30 min after their
treatment with DZP.
In order to assess the involvement of the GABAergic system, a
group of animals were pretreated (i.p.) with physiological saline
solution (Quimibrás Indústrias Químicas S.A., Brazil) or ﬂumaze-
nil (Flumazen®, União Química Lab., Brazil – 1 mg/kg – Carvalho
et al., 2011) 15 min  prior the oral treatment with the test com-
pound apigenin (0.6 mg/kg), the reference drug DZP (1 mg/kg) or
distilled water (control group).
Ethyl ether-induced hypnosis test
Animals were placed in an ethyl ether-saturated glass cage (6 ml,
13 min  of saturation, 30 cm × 20 cm glass cage) after treatments. A
stopwatch was used to record the duration of hypnosis in seconds
(s). The hypnosis time was measured by the loss of the righting
reﬂex, and the recovery of this reﬂex was  considered as the end-
point of the hypnosis (Vieira, 2001).
Voltage clamp analysis
Preparation of stages V–VI oocytes from Xenopus laevis and
synthesis of capped off run-off poly(A+) cRNA transcripts from
linearized cDNA templates (pCMV vector) were performed as pre-
viously described (Khom et al., 2006). Brieﬂy, female Xenopus Laevis
frogs (Nasco, Fort Atkinson, USA) were anaesthetized by exposing
them for 15 min  to a 0.2% solution of MS-222 (methane sulfonate
salt of 3-aminobenzoic acid ethyl ester; Sigma, Vienna, Austria)
before surgically removing parts of the ovaries. Follicle membranes
from isolated oocytes were digested with 2 mg/ml collagenase
solution (Type 1A). Selected stages V–VI oocytes were injected
with about 10–50 nl of DEPC-treated water (diethyl pyrocarbon-
ate) containing the cRNAs at a concentration of approximately
300–3000 pg/nl. The amount of cRNA was  determined by means
of a NanoDrop ND-1000 (Kisker Biotech, Steinfurt, Germany). To
ensure expression of the gamma-subunit, cRNAs for expression of
˛1ˇ22s receptors were mixed in a ratio of 1:1:10, respectively.
After injection, oocytes were stored at 18 ± 8 ◦C for 24–48 h in ND96
solution containing penicillin G (10,000 IU/100 ml)  and strepto-
mycin (10 mg/100 ml). Electrophysiological experiments on GABAA
receptors were performed using the two-microelectrode-voltage-
clamp method at a holding potential of −70 mV,  making use of a
TURBO TEC 01 C ampliﬁer (npi electronic, Tamm, Germany) and an
Axon Digidata 1322A interface (Molecular Devices, Sunnyvale, CA).
Data acquisition was  done using pCLAMP v.9.2. The bath solution
contained 90 mM NaCl, 1 mM KCl, 1 mM MgCl2.6H2O, 1 mM  CaCl2
and 5 mM HEPES (pH 7.4). Microelectrodes were ﬁlled with 3 M KCl.
GABA and apigenin were applied by means of a fast perfusion
system (Screening Tool, npi electronic, Tamm, Germany) (Baburin
et al., 2006) to study the GABA-induced chloride current (IGABA)
modulation. To elicit IGABA, the chamber was  perfused with 120 l
of GABA containing solution at a volume rate between 300 and
1000 ml/s. The IGABA rise time ranged from 100 to 250 ms  (Khom
et al., 2006). To exclude voltage-clamp errors, oocytes with maxi-
mal  current amplitudes >3 mA were discarded.
Potentiation of the IGABA in percent was  deﬁned according to
the formula: IGABA (%) = [I(GABA + apigenin)/IGABA − 1] × 100, where
I(GABA+apigenin) is the current response in the presence of different
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Fig. 1. Effects of the oral treatment with the aqueous extract from the pericarp of P.
quadrangularis (100, 300 and 600 mg/kg) on the duration of the hypnosis induced by
ethyl ether in mice. Diazepam (DZP) (1 mg/kg, p.o.) was  used as control drug. n = 7–8
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Fig. 2. Chromatogram of the aqueous extract from P. quadrangularis pericarp
(5000 g/ml) at 340 nm.  Co-elution with standards showed the presence of vitexin-
2′′-O-xyloside (1) and apigenin (*). See subsection HPLC-DAD analysis in Materials
spiked samples ranged from 99 to 103%, showing that the analytical
approach used in this study is repeatable and accurate.nimals/group. Data are expressed as mean ± S.E.M. *p ≤ 0.05 compared with the
ontrol group. Comparisons were accomplished with one-way ANOVA followed by
unnett’s test or Student’s t test (DZP group × control group).
oncentrations of apigenin, and IGABA is the control GABA-induced
hloride current.
tatistical analysis
Results of the in vivo experiments are expressed as
eans ± S.E.M. Data of the experiments without ﬂumazenil
re-treatment were analyzed by Student’s t test (positive con-
rol groups X control groups) or one-way analysis of variance
ANOVA) followed by Dunnett’s test. In ﬂumazenil pretreatment
rotocol data were analyzed by two-way ANOVA followed by
ewman–Keuls’ test. All of the statistical analyses were performed
sing GraphPad Prism® 5.0 (La Jolla, CA, USA) and/or Statistica
tatsoft® 7.0 (Tulsa, OK, USA). Differences were considered to be
tatistically signiﬁcant when p ≤ 0.05.
For in vitro experiments, Origin Software® (OriginLab Corpora-
ion) was used. Responses were graphed as mean ± S.E.M. from at
east three oocytes out of ≥2 different batches. Statistical signiﬁ-
ance was calculated using one-way ANOVA followed by Tukey’s
est with a conﬁdence interval of p ≤ 0.05.
esults and discussion
In the current study, we evaluated the sedative activity of the
queous extract obtained from pericarps of P. quadrangularis by
eans of ethyl ether-induced hypnosis test. This test allows the
ssessment of sedative effect without introducing possible phar-
acokinetic biases caused by hepatic metabolism of the sleep
nductor, such as in the case of pentobarbital-induced hypnosis test
Duarte et al., 2007; Carvalho et al., 2011).
he ethyl ether-induced hypnosis test of Passiﬂora extract
As depicted in Fig. 1, the pericarp extract of P. quadran-
ularis increased the hypnosis duration (100 and 300 mg/kg –
F3.27 = 3.859, p = 0.0203]), an effect similar to DZP. The seda-
ive activity of P. quadrangularis pericarp extract was not
reviously reported. In the literature was found just one
europharmacological study with this species describing the
nxiolytic-like effect of the hydroethanolic extract from leaves in
ats evaluated in the elevated plus-maze test (Castro et al., 2007).
t higher doses (600 mg/kg), however, the extract did not show a
edative activity. The reason for this ﬁnding should be due to the
act that at higher doses all chemical compounds present in this
xtract could be present at higher amount and the lack of responseand Methods section for the description of the chromatographic conditions.
may  be attributed to the competition between several compounds
of the extract acting in different receptors, even excitatory ones.
The qualitative analysis of the ﬂavonoid constituents in the extract
Regarding the qualitative analysis, most studies are indicating
ﬂavonoids as the main chemical constituents responsible for the
CNS activities of Passiﬂora species (Petry et al., 2001; Li et al., 2011;
Sena et al., 2009). Therefore, the presence of ﬂavonoid constituents
was investigated in P. quadrangularis pericarp extract by co-elution
with apigenin, isoorientin, vitexin-2′′-O-rhamnoside, vitexin-2′′-O-
xyloside, isovitexin and swertisin standards. Previous studies of
our research group identiﬁed the ﬂavonoid vitexin-2′′-O-xyloside
as the major compound in the leaves extract of this plant species
(Costa et al., 2013). Nevertheless, the qualitative HPLC-DAD anal-
ysis of the pericarp extract in co-elution with reference standards
showed that the main ﬂavonoid is not a glycoside, but an agly-
cone identiﬁed as apigenin (Fig. 2). The presence of other minor
ﬂavonoids was visible in the chromatogram but their contents
were very low and could not be isolated. The co-elution procedures
employed allowed the identiﬁcation of one of them as the same gly-
coside found in the leaves, i.e. vitexin-2′′-O-xyloside, and excluded
the presence of isoorientin, vitexin-2′′-O-rahmnoside, isovitexin
and swertisin (Fig. 2). Therefore, as apigenin is present in a much
higher amount, quantitative analysis was  focused in this main
ﬂavonoid.
The quantitative analysis of apigenin in the extract
In order to quantify the content of apigenin in the extract, a
methodology was developed and validated. The parameters speci-
ﬁcity, linearity, accuracy, precision, limit of quantiﬁcation (LOQ)
and limit of detection (LOD) were evaluated (Tables 1 and 2). The
quantiﬁcation demonstrated a good linear relationship between
peak area and concentration (r2 > 0.999). LOQ and LOD  were deﬁned
by the relative standard deviation (RSD > 5%) and by a signal:noise
ratio of 3:1, respectively. The RSD values for repeatability and inter-
mediate precision ranged from 0.5 to 1.9%. The recovery of theSince the procedures of the quantitative analysis were accurate
allowing the correct quantiﬁcation of apigenin in the extract, they
were employed and this ﬂavonoid was  found as 2.449 ± 0.004 mg/g
of P. quadrangularis pericarp extract.
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Table  1
Validation data for apigenin quantiﬁcation by HPLC-DAD.
Flavonoid Linearity range (g/ml) Calibration equationa Correlation factor (r2) LODb (g/ml) LOQb (g/ml)
Apigenin 0.5–40 y = 112834x–23037 0.9996 0.0625 0.25
a Six data points (n = 3).
b LOQ, limit of quantiﬁcation; LOD, limit of detection.
Table 2
Apigenin quantiﬁcation in Passiﬂora species as evaluated by HPLC-DAD.
Flavonoid Repeatabilitya Intermediate precisiona Recoverya,b
Concentration (g/ml) RSD (%) Concentration (g/ml) RSD (%) P. quadrangularis (5000 g/ml)
Mean (%) RSD (%)
Apigenin 1 1.9 10 0.5 103.7 0.1
10  0.7
40  1.1
R
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tSD, relative standard deviation.
a Limits: RSD: <5%.
b Spiked samples with apigenin standard solution at 5 g/ml.
pigenin in the ethyl ether-induced hypnosis test
Apigenin was evaluated in the ethyl ether-induced hypnosis test
t doses of 0.1, 0.3, 0.6 and 1.0 mg/kg. These doses were selected
onsidering the approximated quantity of apigenin present in the
ctive doses of the extract, in view of the quantiﬁcation result
or this compound. Thus, for the doses 100 and 300 mg/kg of P.
uadrangularis pericarp extract, the corresponding quantities of
pigenin are 0.24 and 0.73 mg/kg, respectively.
Among all the administered doses of apigenin, 0.6 mg/kg
emonstrated a sedative effect (F4.35 = 2.657, p = 0.0490), resulting
n a signiﬁcant increase in the sleeping duration (Fig. 3).
The results obtained suggest a positive relationship between
pigenin levels and the sedative effect of the extract. This assump-
ion is supported by other authors who demonstrate that apigenin
t different doses possesses sedative effect. For example, Avallone
t al. (2000) described this effect when apigenin (i.p.) was eval-
ated by spontaneous locomotor behavior in rats. Moreover, by
elemetry tests, Chow et al. (2011) demonstrated that apigenin
p.o.) promoted sedative effect in C57BL/6J mice.
On the other side, when apigenin was administered in the doses
f 0.1 and 0.3 mg/kg, i.e.,  the approximated amount of apigenin
n 100 mg/kg of P. quadrangularis pericarp extract, this ﬂavonoid
id not show any sedative activity (Fig. 3), showing a U inverted
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ig. 3. Effects of the oral treatment with the ﬂavonoid apigenin (0.1, 0.3, 0.6, and
.0  mg/kg) on the duration of ethyl ether-induced hypnosis in mice. Diazepam (DZP)
1 mg/kg, p.o.) was  used as a standard drug. n = 8 animals/group. Data are expressed
n  terms of means ± S.E.M. *p ≤ 0.05 compared with the control group. Comparisons
ere accomplished with one-way ANOVA followed by Dunnett’s test or Student’s t
est (DZP group × control group).dose-effect curve. Some ﬁndings indicate that, as occurs in our
results, the hormesis model could predicts responses in the low
doses zone very well in biological tests (Calabrese, 2009). This
fact indicates that the effect observed for pericarp extract is not
due only to the content of apigenin. Actually, this compound can
be the main responsible, but probably there is also a signiﬁcant
contribution of other compounds.
Studying a potential involvement of the GABAergic system in the
sedative activity of apigenin
Losi et al. (2004) reported an interaction of apigenin with the
GABAergic and glutamatergic neurotransmission in cultured cor-
tical neurons. These neurotransmitter systems play a key role in
controlling the excitability of the brain and are thus targeted by
many psychoactive substances as well as clinically used drugs
(Mihic and Harris, 2011). In addition, Lolli et al. (2007) showed
that methanol and hydromethanol extracts from P. actinia exerts
anxiolytic-like and sedative effects in mice after oral administra-
tion. Authors also show that previous administration of ﬂumazenil
in the elevated plus maze test indicate that the anxiolytic-like activ-
ity is related to the inﬂuence of the GABAergic activation (Lolli et al.,
2007) pointing that this pathway can be modulate by Passiﬂora
extracts.
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Fig. 4. Effects of the oral treatment of apigenin (API – 0.6 mg/kg), diazepam (DZP –
1.0  mg/kg) and water in animals pre-treated (i.p.) with ﬂumazenil (FMZ – 1.0 mg/kg)
or  saline on the duration of hypnosis induced by ethyl ether in mice. DZP was  used as
control drug. n = 7–8 animals/group. Data are expressed as mean ± S.E.M. *,&p ≤ 0.05
compared with: saline/water and saline/DZP groups, respectively (two-way ANOVA
test  followed by Newman–Keuls’ test).
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Fig. 5. Modulation of IGABA through GABAA receptors (˛1ˇ22s) at GABA concentrations eliciting 3–7% of the maximal GABA response (EC3–7) by apigenin (A) and luteolin
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As depicted in Fig. 3, 0.6 mg/kg of apigenin increased sedation in
ice in the ethyl ether-induced hypnosis test. This sedative effect
as blocked by application of ﬂumazenil at a dose of 1.0 mg/kg
Fig. 4). Since ﬂumazenil is a benzodiazepine antagonist, this result
ndicates that apigenin might interact with the benzodiazepine-
inding site of GABAA receptors to promote its sedative effect.
We  have therefore expressed GABAA receptors composed of ˛1,
2 and 2S subunits in Xenopus laevis oocytes and studied a poten-
ial modulation of GABA-induced currents (IGABA) by apigenin and
uteolin making use of the 2-microelectrode voltage-clamp tech-
ique and a fast perfusion system.
However, as illustrated in Fig. 5A, apigenin failed to enhance
GABA through this receptor subtype at all tested concentrations
0.1–50 M).  Actually, as not expected, it inhibited IGABA at the
igher concentration, a result that has further investigated.
Taking into account that the sedative effect of apigenin was
bserved after oral application it is tempting to speculate that not
nly apigenin, but any of the metabolites formed after gastroin-
estinal and/or hepatic metabolism might in vivo modulate GABAA
eceptors. Gradolatto et al. (2004) reported that at least seven com-
ounds are originated from hepatic metabolism of apigenin with
uteolin being identiﬁed as the main metabolite. Therefore, we  have
lso analyzed the modulation of IGABA through ˛1ˇ22S GABAA
eceptors expressed in Xenopus oocytes by luteolin. As illustrated
n Fig. 5B, luteolin also did not elicited a signiﬁcant enhancement
f IGABA. Thus, this result could not explain the sedative effect of
pigenin observed after oral treatment of mice, but it shows the
mportance of better understand the metabolism of in vivo admin-
stered compounds.
Other possible explanation for our in vivo ﬁndings might be
hat apigenin can be acting as a second order modulator. Previ-
us studies showed that apigenin did not modulate IGABA when
pplied alone to the receptor, but it showed strong effects when co-
pplied with another GABAA receptor modulator such as diazepam
Campbell et al., 2004).In addition, the inﬂuence of other GABAA receptor subtypes in
he sedative activity of apigenin could not be discarded. In this
ense, it was previously showed that ˛5 subunit of GABAA receptors
xerts inﬂuence of the sedative activity (Savic´ et al., 2008). different oocytes of two different oocyte batches. Statistical signiﬁcance (p < 0.05,
In conclusion, this study provides evidences that the aqueous
extract from the pericarp of P. quadrangularis induces sedation in
mice. In addition, apigenin, the main ﬂavonoid found in the extract,
also induced sedative effect, suggesting that this ﬂavonoid plays an
important role in the sedative effect of the extract. Furthermore, a
potential involvement of GABAA receptors in mediating the seda-
tive effect of apigenin was demonstrated in vivo but not in vitro and
the molecular mechanism remains to be elucidated.
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